During the past decade, Rigshospitalet; Medicinsk gastroenterologisk klinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rigshospitalet; Medicinsk gastroenterologisk klinik" are "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Rigshospitalet; Medicinsk gastroenterologisk klinik" in a lesser frequency.

Most popular intervention types in "Rigshospitalet; Medicinsk gastroenterologisk klinik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (1 trials), "Etrozulimab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rigshospitalet; Medicinsk gastroenterologisk klinik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rigshospitalet; Medicinsk gastroenterologisk klinik". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rigshospitalet; Medicinsk gastroenterologisk klinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rigshospitalet; Medicinsk gastroenterologisk klinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".